Roundtable: Making expedited regulatory pathways work for global drug development programs

With many differing expedited regulatory mechanisms available across the globe, how can you select the right pathway and make it work simultaneously in different regions? This panel discussion, hosted by Applied Clinical Trials, will include a lively conversation with Parexel regulatory experts – former regulators from USA, Europe, and China.

Register here

Five early planning strategies for biotechs

In drug development, early and simultaneous management of commercial, clinical, regulatory, and market access strategy is the surest path to approval, investment, reimbursement, and market share. Get the Parexel Biotech perspective on early strategies for bringing new treatments to the patients who need them.

Download eBook

Risk-based Quality Management (RBQM) Services

The new world order of clinical research demands a fresh look at end-to-end clinical practices. Parexel’s approach to risk-based quality management (RBQM) is a holistic risk strategy rooted in Quality by Design principles, that relies on critical data to inform decision-making throughout clinical programs and trials.

Learn more

Navigating Long COVID Syndrome

During this time, we continue to be committed to our customers’ business while putting the safety of patients, partners and our employees at the heart of everything we do.

Long COVID Syndrome

COVID-19 Response

COVID-19 Data Clearinghouse

Leadership Lessons on Diversity, Equity, & Inclusion, and the Future of Work

Featuring Jamie Macdonald, CEO, Parexel & Amir Kalali, Chairman & Chief Curator, CNS Summit

Created as part of CNS Summit 2021, a year-round experience designed for R&D Leaders in Life Sciences, the full discussion is now available here. 

Watch now